XBKK
LPH
Market cap78mUSD
Nov 12, Last price
3.64THB
Name
Ladprao General Hospital PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ladprao General Hospital Public Company Limited, including its subsidiaries, functions as a prominent healthcare provider in Thailand, primarily through the operation of the private Ladprao General Hospital. This facility offers an extensive range of medical specialties, such as neurology, cardiology, hypertension management, dentistry, hemodialysis, pediatrics, refractive eye surgery, women's health, aesthetic and dermatological services, laser treatments, and ear, nose, and throat care. The hospital also hosts specialized centers for health screenings, gastroenterology, hepatology, orthopedics, physical therapy, and rehabilitation. Expanding beyond direct patient care, the company delivers scientific analytical and diagnostic services for industries including food, agriculture, pharmaceuticals, and environmental protection. It further conducts instrument calibration, quality inspections, and provides certifications that adhere to stringent quality systems and international benchmarks. Other ventures include hospital management and consulting, mobile health check-ups, and professional nursing services for industrial sites and other organizations. Moreover, the company actively researches, develops, cultivates, and distributes herbal products with medicinal benefits. Established in 1990, Ladprao General Hospital Public Company Limited is headquartered in Bangkok, Thailand.
Key people
Somsak Lohlekha
Non-Executive Chairman of the Board · since 2021
Ungoon Chantanavanich
Chief Executive Officer, Executive Director · since 2021
Pipat Savetvilas
Non-Executive Vice Chairman of the Board · since 2021
Jirawan Menghong
Managing Director · since 2019
Chomsri Chaiwachirasak
Deputy Managing Director - Finance and Account · since 2015
Vitavas Pirmphol
Deputy Managing Director, Company Secretary · since 2015
Ruengrit Hassakul
Medical Department Administrator · since 2021
Pramote Phunapanon
Hospital Director · since 2020
Sawanan Watcharawanich
Medical Department Administrator and Quality Center · since 2020
Vidchuda Ampornphol
Non-Executive Director · since 2021
Somchao Tanterdtham
Non-Executive Director · since 2021
Wirat Wongsangnak
Non-Executive Director · since 2021
Kulthon Nakaporm
Non-Executive Independent Director · since 2021
Benjawan Thanapaisanpipat
Non-Executive Independent Director · since 2021
Thippawan Uthaisang
Non-Executive Independent Director · since 2021
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||